MedTrace Logo

Lovenox With Aspirin in Thawed Blastocyst Transfer

NCT06133803 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2024-02-21

No results posted yet for this study

Summary

This prospective randomized trial will compare outcomes in patients receiving aspirin in combination with a low-molecular weight heparin and those under this center's standard protocol receiving neither medication, in order to determine if these medications may improve success rates.

Conditions

  • Infertility, Female

Interventions

DRUG

Lovenox

A low-molecular-weight heparin, 40mg daily injection.

DRUG

Aspirin

Aspirin 81mg daily tablet.

PROCEDURE

Embryo transfer

Embryo transfer

Sponsors & Collaborators

  • Fertility Center of Las Vegas

    lead INDUSTRY

Principal Investigators

  • Bruce Shapiro, MD, PhD · Fertility Center of Las Vegas

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-26
Primary Completion
2024-12-15
Completion
2024-12-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06133803 on ClinicalTrials.gov